Unknown

Dataset Information

Cardiovascular Outcomes in Relation to Antihypertensive Medication Use in Women with and Without Cancer: Results from the Women's Health Initiative.


ABSTRACT:

Background

Recent clinical trials have evaluated angiotensin-converting enzyme (ACE) inhibitors (ACEis), angiotensin receptor blockers (ARBs), and beta blockers (BBs) in relation to cardiotoxicity in patients with cancer, typically defined by ejection fraction declines. However, these trials have not examined long-term, hard clinical endpoints. Within a prospective study, we examined the risk of heart failure (HF) and coronary heart disease (CHD) events in relation to use of commonly used antihypertensive medications, including ACEis/ARBs, BBs, calcium channel blockers (CCB), and diuretics, comparing women with and without cancer.

Materials and methods

In a cohort of 56,997 Women's Health Initiative study participants free of cardiovascular disease who received antihypertens

SUBMITTER: Reding KW 

PROVIDER: S-EPMC7418354 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature